The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for BioAccess sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Bioaccess is a medical device company that develops, manufactures and markets surgical devices. The company’s products portfolio comprise hand procedure kits, traction pin kits, bone marrow collection system, disposable traction bow, small bone tools and extension line kit. It offers semi-reusable power tool technology for various procedures including aesthetic surgery, spine surgery, sports medicine, robotic surgery, maxillofacial surgery, and others. Bioaccess also develops semi-reusable tools for military application, and forward surgical hospitals. Its products are used in operating room, emergency room, and surgicenters. The company also offers customer support for its products, which are designed for physicians. Bioaccess is headquartered in Baltimore, Maryland, the US.
The key metrics of BioAccess related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As BioAccess is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as BioAccess.
For a detailed understanding of the performance of BioAccess, buy the report here.